维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Hollmig"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines 显示文摘	Gafur 0 A Copley L A Hollmig S T	2008	J Pediatr Orthop2008，28，7：	1
2	High serum free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis显示文摘	van Rhee F Bolejaek V Hollmig K	2007	Blood2007，110，3：	1
3	Recognition of non- self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2显示文摘	Hollmig ST Ariizumi K Cruz PD Jr	2009	Glycobiology2009，19，6：	1
4	The impact of thecurrent epidemiology of pediatric musculoskeletal infection onevaluation and treatment guidelines显示文摘	Gafur 0 A Copley L A Hollmig S T	2008	J Pediatr Orthop2008，28，7：	1
5	The impact of the cur- rent epidemiology of pediatric musculoskeletal infection on evalua- tion and treatment guidelines显示文摘	Gafur OA Copley LA Hollmig ST	2008	J Pediatr Orthop2008，28，7：	1
6	Recognition of non-self-polysaccharides by C-type lectin receptors dectin- 1 and dectin-2显示文摘	Hollmig ST Ariizumi K Cruz PD	2009	Glycobiology2009，19，6：	1
7	Malignant fibrous histiocytoma: changing perceptions and management challenges显示文摘	Henderson M T Hollmig S T	2012	J Am Acad Dermatol2012，67，6：	1
8	Recognition of nonself-polysaccharides by C-type lectin receptors dectin-1 and dectin-2显示文摘	Hollmig ST Ariizumi K Cruz PD Jr		0，，：	1
9	High serum free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis 显示文摘	van Rhee F Bolejack V Hollmig K	2007	Blood2007，110，：	1
10	High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis 显示文摘	VAN RHEE F BOLEJACK V HOLLMIG K	2007	Blood2007，110，3：	1
11	Spindle cell neoplasms encountered in dermatologic surgery: a review 显示文摘	Hollmig ST Sachdev R Cockerell CJ	2012	Dermatol Surg2012，38，6：	1
12	Lack of efficacy with 1064-rim neodymimn: yttrium-aluminum-gm'net laser for the treatment of onychomycosis: a randomized, controlled trial 显示文摘	Hollmig ST Rahman Z Henderson MT	2014	J Am Acad Dermatol2014，70，5：	1
13	High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive muhiple myeloma subtype with poor prognosis 显示文摘	van Rhee F Bolejack V Hollmig K	2007	Blood2007，110，3：	1
14	Malignant fibrous histiocytoma: changing perceptions and management challenges显示文摘	Henderson MT Hollmig ST	2012	J Am Acad Dermatol2012，67，6：	1
15	Addition of bortezomib(Velcade) to high dose melphalan(Vel-Mel) as an effective conditioning regimen with autologous stem cell support in multiple myeloma(MM)显示文摘	HOLLMIG K STOVE J TALAMO G	2004	Blood2004，104，：	1
16	High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis显示文摘	van Rhee F Bolejack V Hollmig K	2007	Blood2007，110，3：	1
17	Malignant fibrous histiocytoma: Changing perceptions and management challenges显示文摘	Michael T. Henderson S. Tyler Hollmig	2012	Journal of the American Academy of Dermatology2012，，6：	1
18	Severe bleeding complications in HIVpositive haemophiliac patients treated with protease inhibitors显示文摘	Hollmig KA Beck SB Doll DC	2001	Eur J Med Res2001，6，3：	1
19	Addition of bortezomib(Velcade) to high dose melphalan (Vel- Mel) as an effective conditioning regimen with autologous stem cell support in multiple myeloma (MM)显示文摘	Hollmig K Stove J Talamo G	2004	Blood2004，104，：	1
20	High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis 显示文摘	van Rhee F Bolejack V Hollmig K	2007	Blood2007，110，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示